These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8192819

  • 1. Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Reid T, Alving BM.
    Am J Hematol; 1994 Apr; 45(4):352-3. PubMed ID: 8192819
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR, Mahaffey KW, Lewis BE, Weitz JI, Berkowitz SD, Ohman EM, Califf RM.
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
    Smythe MA, Warkentin TE, Stephens JL, Zakalik D, Mattson JC.
    Am J Hematol; 2002 Sep; 71(1):50-2. PubMed ID: 12221676
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT, Elliott WG, Zia AA.
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
    Cannon CP, Maraganore JM, Loscalzo J, McAllister A, Eddings K, George D, Selwyn AP, Adelman B, Fox I, Braunwald E.
    Am J Cardiol; 1993 Apr 01; 71(10):778-82. PubMed ID: 8456753
    [Abstract] [Full Text] [Related]

  • 16. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA, Warkentin TE.
    Ann Pharmacother; 2002 Sep 01; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract] [Full Text] [Related]

  • 17. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep 25; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S, Carr ME.
    Angiology; 2001 Oct 25; 52(10):711-5. PubMed ID: 11666136
    [Abstract] [Full Text] [Related]

  • 20. Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.
    White HD, Ellis CJ, French JK, Aylward P.
    Aust N Z J Med; 1998 Aug 25; 28(4):551-4. PubMed ID: 9777138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.